News

SelectQuote (SLQT) – Can It Cut Loose Its Heavy Debt Anchor?

Financial Services
0 min read


Thursday, February 29, 2024

Patrick McCann, CFA, Research Analyst, Noble Capital Markets, Inc.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Initiating coverage with an Outperform rating and $5 price target. SelectQuote (NYSE: SLQT) is an insurance distribution and healthcare services organization, which is positioned to benefit from a growing population of Medicare beneficiaries. In our view, the company’s unique combination of health insurance distribution and home-direct pharmacy services represents an opportunity to drive high value per customer in a cost efficient manner. Our favorable rating reflects a strong revenue growth outlook with improving cash flow generation. 

Synergistic business model. The company’s health insurance distribution (primarily Medicare Advantage policies) and home-direct pharmacy businesses largely share a target customer base. This allows the company to economize on customer acquisition costs for its two largest segments. Taken together, the two business segments generated a revenue/customer acquisition cost (CAC) multiple of 4.2x over the trailing 12 months (as of December 31, 2023). 


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy